Skip to main content
. 2014 Mar 7;9(3):e91153. doi: 10.1371/journal.pone.0091153

Table 4. Comparison of the mean [standard deviation (SD)] scores of different motor, psychiatric, fatigue and quality of life (PDQ-39) scales between subgroups of Parkinson’s disease (PD) patients regarding nutritional status (MNA).

Scale Domain Abnormal nutritional status (n = 40) Normal nutritional status (n = 106) t-value P-value
Baseline Age (yr) 61.3 (12.3) 61.3 (9.8) −0.02 .982
Disease duration (yr) 8.2 (6.9) 6.2 (4.6) −2.02 .045*
Body mass index (BMI) (kg/m2) 23.9 (3.8) 26.6 (4.3) 3.57 .001*
Daily levodopa dose
Crude (mg) 817 (450) 841 (490) 0.27 .789
Weight-adjusted (mg/kg) 13.55 (8.92) 11.50 (6.94) −1.46 .146
PDQ39 Mobility 45.6 (26.6) 19.4 (20.7) −5.61 <.001*
Activities of daily living (ADL) 38.4 (28.9) 18.0 (17.9) −3.97 <.001*
Emotional well-being 41.3 (22.4) 22.1 (20.8) −4.90 <.001*
Stigma 22.0 (24.4) 21.5 (25.4) −0.11 .913
Social support 13.0 (17.2) 5.1 (10.9) −2.51 .016*
Cognitive impairment 25.5 (20.5) 13.5 (16.6) −3.64 <.001*
Communication 24.6 (23.9) 10.3 (13.6) −3.56 .001*
Bodily discomfort 32.5 (20.3) 16.4 (19.6) −4.30 <.001*
Disease Severity UPDRS: Part I-mental 3.8 (3.2) 1.3 (1.4) −4.69 <.001*
UPDRS: Part II-ADL 15.9 (7.8) 9.4 (5.8) −5.17 <.001*
UPDRS: Part III-motor 20.6 (10.1) 13.3 (7.4) −4.18 <.001*
UPDRS: Part IV-complications 5.1 (3.4) 2.9 (2.2) −3.80 <.001*
a. Dyskinesia 1.7 (2.5) .8 (1.4) −2.08 .042*
b. Wearing off 2.3 (1.4) 1.5 (1.2) −3.06 .003*
UPDRS: Total 45.9 (18.0) 26.4 (13.6) −6.50 <.001*
Hoehn & Yahr stage # 2.5 (1.0) 2.0 (1.5) −4.55 <.001*
Schwab & England stage (%) 71.2 (19.6) 85.7 (13.9) 4.29 <.001*
HADS Anxiety 8.8 (5.2) 5.9 (4.9) −3.08 .002*
Depression 9.0 (4.2) 3.6 (3.5) −7.77 <.001*
FSS Fatigue 5.4 (1.5) 4.2 (2.0) −4.00 <.001*

# Values are presented as median (IQR).